trading
N.Y. Attorney General Sues Former Emergent BioSolutions CEO Robert Kramer for Insider Trading
insider trading; Emergent BioSolutions; Robert Kramer; New York AG; Letitia James; COVID-19 vaccine; AstraZeneca; stock sales
Legislators Profit from Bill Restricting Chinese Biotech Firms
Congress, stock trading, China biotech ban, financial gain, legislative influence, conflict of interest.